Loud snoring at night. Pauses in breathing followed by gasps for air while you’re asleep. Excessive daytime fatigue. Frequent nodding off in front of the TV or even when behind the wheel of a car.

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. ResMed (NYSE:RMD) is seeing growing use of wearable devices for sleep apnea pre ...

ResMed’s myAir, a program for CPAP users to track sleep apnea treatment, is now available in the U.S. The app can be used by those working with the ResMed Air10. Courtesy of ResMed The web application ...

As Philips stares down an international recall of more than 2 million of its CPAP and sleep apnea machines, the respiratory devicemaker ResMed is looking to pick up the slack—but the surge in demand ...

New study confirms that engaging patients with digital self-monitoring in their treatment through myAir improves adherence ResMed today announced new European research from Price Waterhouse Coopers ...

When do medical device companies sound like parents proudly touting how their toddlers eat vegetables? When they can demonstrate that thousands of patients are adhering to a difficult therapy using ...

Connected sleep devicemaker ResMed today released the AirSense 11, its latest CPAP machine iteration, which includes a host of new features to treat obstructive sleep apnea. The new machine has many ...

ResMed, Inc. RMD recently presented favorable results from a research study on positive airway pressure (PAP) at the American Thoracic Society’s 2019 ATS International Conference. The findings ...

The new AirTouch™ N30i tube-up nasal mask for CPAP combines softness, breathability, and a high-performance, durable seal to provide exceptional comfort SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- ...

SAN DIEGO--(BUSINESS WIRE)--ResMed (NYSE: RMD) (ASX: RMD) today introduced AirFit N30, the world’s first tube-down nasal cradle CPAP mask with a front-facing tube – a brand-new option for sleep apnea ...